Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 201 - 210 of 354 results
-
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus
Date:
08/16/2022Topics:
Lead Investigators:
-
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection
Date:
08/12/2022Lead Investigators:
-
HPTN 103 Protocol Leadership support
Date:
08/01/2022Lead Investigators:
-
Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB)
Date:
08/01/2022Topics:
Lead Investigators:
-
Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfection
Date:
08/01/2022Locations:
Topics:
Lead Investigators:
-
FY25 STD Services: STD General Funds: Delivery of Primary Health Care Services and Communicable Disease Control Services
Date:
07/01/2022Locations:
Lead Investigators:
-
Long-term outcomes of SARS-CoV-2 infections and risk factors of COVID-19 vaccine breakthrough infections in kidney transplant recipients
Date:
07/01/2022Lead Investigators:
-
A phase 3, multicenter, prospective, randomized, double-blind study of two treatment regiments for candidemia and/or invasive candidiasis: Intravenous echinocandin followed by oral ibreafungerp versus intravenous echinocandin followed by fluconazole
Date:
07/01/2022Topics:
Lead Investigators:
-
Access Telehealth
Date:
07/01/2022Locations:
Topics:
Lead Investigators:
-
The Clinical Guidelines Program
Date:
07/01/2022Topics:
Lead Investigators: